Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Cynapsus Therapeutic Company Profile (NASDAQ:CYNAF)

Consensus Ratings for Cynapsus Therapeutic (NASDAQ:CYNAF) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $2.25 (270.13% upside)

Analysts' Ratings History for Cynapsus Therapeutic (NASDAQ:CYNAF)
Show:
DateFirmActionRatingPrice TargetDetailsShare
1/14/2014Noble FinancialBoost Price TargetBuy$1.75 -> $2.25ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2012 forward)